Piyada Sitthideatphaiboon

LKB1 and KEAP1/NRF2 Pathways Cooperatively Promote Metabolic Reprogramming with Enhanced Glutamine Dependence in <i>KRAS</i> -Mutant Lung Adenocarcinoma

Ana Galán‐Cobo, Piyada Sitthideatphaiboon, Xiao Qu et al. · Cancer Research · 2019 · 274 citations · Full text

Life Sciences, Molecular Biology, Oncology +17

<i>STK11</i> /LKB1 Mutations in NSCLC Are Associated with KEAP1/NRF2-Dependent Radiotherapy Resistance Targetable by Glutaminase Inhibition

Piyada Sitthideatphaiboon, Ana Galán‐Cobo, Marcelo V. Negrão et al. · Clinical Cancer Research · 2020 · 115 citations · Full text

Medicine, Molecular Genetics, Oncology +17

Neoadjuvant Osimertinib for Resectable <i>EGFR</i> -Mutated Non–Small Cell Lung Cancer

Jianxing He, Masahiro Tsuboi, Walter Weder et al. · Journal of Clinical Oncology · 2025 · 61 citations · Full text

Medicine, Oncology, Pharmacotherapy +17

Inhibition of nonsense-mediated decay rescues p53β/γ isoform expression and activates the p53 pathway in MDM2-overexpressing and select p53-mutant cancers

Jayanthi Gudikote, Tina Cascone, Alissa Poteete et al. · Journal of Biological Chemistry · 2021 · 38 citations · Full text

Life Sciences, Molecular Biology, Oncology +14

Co-occurrence CDK4/6 amplification serves as biomarkers of de novo EGFR TKI resistance in sensitizing EGFR mutation non-small cell lung cancer

Piyada Sitthideatphaiboon, Chinachote Teerapakpinyo, Krittiya Korphaisarn et al. · Scientific Reports · 2022 · 36 citations · Full text

Medicine, Molecular Biology, Oncology +17